• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Abdominal Pain (1685); Fatigue (1849); Peritonitis (2252)
Event Date 01/17/2024
Event Type  Injury  
Manufacturer Narrative
This report is for a breach in aseptic technique which resulted in peritonitis. per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy. should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
A peritoneal dialysis (pd) patient experienced a breach in aseptic technique which resulted in peritonitis.The breach in aseptic technique was not further described.The peritonitis was manifested by severe weakness, cloudy pd fluid and abdominal pain.A day prior to the peritonitis diagnosis, the patient was hospitalized due to another indication.The patient was treated with vancomycin injection (1gm, intraperitoneal, every 72 hourly, ongoing), ceftazidime injection (1gm, intraperitoneal, once daily, ongoing) and fluconazole tablet (150mg, oral, once daily, ongoing) for peritonitis.At the time of this report, the patient remained hospitalized and was recovering from the events.Pd therapy was ongoing.It was reported that the patient was retrained on the proper aseptic technique.No additional information is available.
 
Manufacturer Narrative
Additional information: b5, b6 and b7.B5: upon follow-up, it was reported that antibiotic treatment was discontinued (on an unknown date).On an unknown date, the pd catheter was removed, pd therapy was discontinued and the patient was transferred to hemodialysis.At the time of this report, the patient has recovered from abdominal pain; however, was recovering from peritonitis, severe weakness, abdominal pain and cloudy pd fluid.The device was not returned and the lot number is unknown; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NI
Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
ni
ni
ni
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key18672750
MDR Text Key334947013
Report Number1416980-2024-00441
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/17/2024
Initial Date FDA Received02/08/2024
Supplement Dates Manufacturer Received02/09/2024
Supplement Dates FDA Received03/04/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DIANEAL PD2 2.5%.; EXTRANEAL PD2 7.5%.; UNKNOWN BAXTER PD DISPOSABLES.; UNKNOWN PD CATHETER.
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age48 YR
Patient SexMale
-
-